Research article · 28 Dec 2023
Short communicationPublished 10 May 2021
SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimers disease
1LSU Neuroscience Center, Louisiana State University Health Science Center, New Orleans LA, AZ USA; 2Department of Neurology, LSU Neuroscience Center Louisiana State University Health Science Center, New Orleans LA, AZ USA; 3Department of Ophthalmology, LSU Neuroscience Center Louisiana State University Health Science Center, New Orleans LA, AZ USA
Similar by topic
Short communication · 18 Nov 2022
Molecular Docking of Carrageenans for Main Protease (Mpro) and Angiotensin-Converting Enzyme 2 (ACE2) of SAR-COV-2
Research article · 31 Jan 2023
Can SARs-CoV-2 Infect Nasal Epithelium and Cause Parkinson's Disease?
Review article · 26 Oct 2022
Potential Mechanisms for Human Genome Integration of Genetic Code from SARS-CoV-2 mRNA Vaccination: Implications for Disease
Mini review · 30 Jul 2022
Effect of Vitamin D on Parkinson’s disease patients affected with SARS-CoV-2
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Walter J. Lukiw”
